Drug recall D-0736-2022
Product
Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, NDC 13107-014-01.
Reason for recall
Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.
Lots and codes
Lot: 01421008A1, Exp 03/2023
Recall details
- Recalling firm
- Aurolife Pharma, LLC, Dayton, NJ
- Quantity
- 4080 bottles
- Distribution
- Nationwide in the USA and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 17, 2022
- Terminated
- March 25, 2024
Related products
- Glycopyrrolate – drug information
- NDC 13107-015 Glycopyrrolate · Glycopyrrolate 2 mg/1 · Aurolife Pharma LLC
- NDC 13107-014 Glycopyrrolate · Glycopyrrolate 1 mg/1 · Aurolife Pharma LLC